Controversial Drug Manufacturer Finds Common Ground

It was just a matter of time before Celgene Corp. would cross paths with the Thalidomide Victims Association of Canada (TVAC) in its quest to obtain FDA clearance to market and sell Thalomid, a version of the controversial drug Thalidomide.